Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01010789 · ClinicalTrials.gov registry record · Phase 3
Armodafinil in Binge Eating Disorder (BED)
A Phase 3 study, sponsored by Lindner Center of HOPE.
- Completed
- Registry status
- Phase 3
- Development phase
- 60
- Enrollment target
NCT01010789 is a Phase 3 study that has completed, run by Lindner Center of HOPE. The registered enrollment target is 60 participants.
The verdict
NCT01010789, a Phase 3 study, has completed, sponsored by Lindner Center of HOPE.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this research study is to study the effectiveness, tolerability and safety of armodafinil in outpatients with binge eating disorder.
Interventions
- DRUG Matching placebo
- DRUG Armodafinil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2009-11 |
| Est. Completion | 2015-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01010789
The ClinicalTrials.gov registry entry for NCT01010789 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lindner Center of HOPE, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Matching placebo is the first listed.
NCT01010789 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01010789 about?
NCT01010789 is a clinical study titled "Armodafinil in Binge Eating Disorder (BED)". The purpose of this research study is to study the effectiveness, tolerability and safety of armodafinil in outpatients with binge eating disorder.
What is the current status of trial NCT01010789?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 60 participants. The study started on 2009-11. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01010789?
The interventions under investigation include: Matching placebo (DRUG), Armodafinil (DRUG).
Who is sponsoring clinical trial NCT01010789?
This trial is sponsored by Lindner Center of HOPE, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.